Selected research
Market Analysis & Forecast
Global Salbutamol Oral Liquid Market Analysis and Forecast 2026-2032
Market perspective
The global Salbutamol Oral Liquid market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Salbutamol Oral Liquid is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Salbutamol Oral Liquid is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Salbutamol Oral Liquid is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Salbutamol Oral Liquid is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Salbutamol Oral Liquid include Apotex, Aurobindo Pharma, Lupin Pharmaceuticals, Perrigo Company, Wockhardt, GlaxoSmithKline, Mylan Pharmaceuticals, Novartis Pharmaceuticals Corporation and Sandoz, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Salbutamol Oral Liquid, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Salbutamol Oral Liquid, also provides the sales of main regions and countries. Of the upcoming market potential for Salbutamol Oral Liquid, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Salbutamol Oral Liquid sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Salbutamol Oral Liquid market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Salbutamol Oral Liquid sales, projected growth trends, production technology, application and end-user industry.
Salbutamol Oral Liquid Segment by Company
Apotex
Aurobindo Pharma
Lupin Pharmaceuticals
Perrigo Company
Wockhardt
GlaxoSmithKline
Mylan Pharmaceuticals
Novartis Pharmaceuticals Corporation
Sandoz
Teva Pharmaceuticals
Salbutamol Oral Liquid Segment by Type
Ipratropium Bromide
Salbutamol Sulfate
Salbutamol Oral Liquid Segment by Application
Hospital
Clinic
Others
Salbutamol Oral Liquid Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Salbutamol Oral Liquid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Salbutamol Oral Liquid and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Salbutamol Oral Liquid.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Salbutamol Oral Liquid in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Salbutamol Oral Liquid manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Salbutamol Oral Liquid sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Ipratropium Bromide
- Salbutamol Sulfate
Applications
- Hospital
- Clinic
- Others
Companies covered
- Apotex
- Aurobindo Pharma
- Lupin Pharmaceuticals
- Perrigo Company
- Wockhardt
- GlaxoSmithKline
- Mylan Pharmaceuticals
- Novartis Pharmaceuticals Corporation
- Sandoz
- Teva Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Salbutamol Oral Liquid Market by Type
- 1.2.1 Global Salbutamol Oral Liquid Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Ipratropium Bromide
- 1.2.3 Salbutamol Sulfate
- 1.3 Salbutamol Oral Liquid Market by Application
- 1.3.1 Global Salbutamol Oral Liquid Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Salbutamol Oral Liquid Market Dynamics
- 2.1 Salbutamol Oral Liquid Industry Trends
- 2.2 Salbutamol Oral Liquid Industry Drivers
- 2.3 Salbutamol Oral Liquid Industry Opportunities and Challenges
- 2.4 Salbutamol Oral Liquid Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Salbutamol Oral Liquid Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Salbutamol Oral Liquid Revenue by Region
- 3.2.1 Global Salbutamol Oral Liquid Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Salbutamol Oral Liquid Revenue by Region (2021-2026)
- 3.2.3 Global Salbutamol Oral Liquid Revenue by Region (2027-2032)
- 3.2.4 Global Salbutamol Oral Liquid Revenue Market Share by Region (2021-2032)
- 3.3 Global Salbutamol Oral Liquid Sales Estimates and Forecasts 2021-2032
- 3.4 Global Salbutamol Oral Liquid Sales by Region
- 3.4.1 Global Salbutamol Oral Liquid Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Salbutamol Oral Liquid Sales by Region (2021-2026)
- 3.4.3 Global Salbutamol Oral Liquid Sales by Region (2027-2032)
- 3.4.4 Global Salbutamol Oral Liquid Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Salbutamol Oral Liquid Revenue by Manufacturers
- 4.1.1 Global Salbutamol Oral Liquid Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Salbutamol Oral Liquid Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Salbutamol Oral Liquid Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Salbutamol Oral Liquid Sales by Manufacturers
- 4.2.1 Global Salbutamol Oral Liquid Sales by Manufacturers (2021-2026)
- 4.2.2 Global Salbutamol Oral Liquid Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Salbutamol Oral Liquid Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Salbutamol Oral Liquid Sales Price by Manufacturers (2021-2026)
- 4.4 Global Salbutamol Oral Liquid Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Salbutamol Oral Liquid Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Salbutamol Oral Liquid Manufacturers, Product Type & Application
- 4.7 Global Salbutamol Oral Liquid Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Salbutamol Oral Liquid Market CR5 and HHI
- 4.8.2 2025 Salbutamol Oral Liquid Tier 1, Tier 2, and Tier 3
5 Salbutamol Oral Liquid Market by Type
- 5.1 Global Salbutamol Oral Liquid Revenue by Type
- 5.1.1 Global Salbutamol Oral Liquid Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Salbutamol Oral Liquid Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Salbutamol Oral Liquid Revenue Market Share by Type (2021-2032)
- 5.2 Global Salbutamol Oral Liquid Sales by Type
- 5.2.1 Global Salbutamol Oral Liquid Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Salbutamol Oral Liquid Sales by Type (2021-2032) & (k units)
- 5.2.3 Global Salbutamol Oral Liquid Sales Market Share by Type (2021-2032)
- 5.3 Global Salbutamol Oral Liquid Price by Type
6 Salbutamol Oral Liquid Market by Application
- 6.1 Global Salbutamol Oral Liquid Revenue by Application
- 6.1.1 Global Salbutamol Oral Liquid Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Salbutamol Oral Liquid Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Salbutamol Oral Liquid Revenue Market Share by Application (2021-2032)
- 6.2 Global Salbutamol Oral Liquid Sales by Application
- 6.2.1 Global Salbutamol Oral Liquid Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Salbutamol Oral Liquid Sales by Application (2021-2032) & (k units)
- 6.2.3 Global Salbutamol Oral Liquid Sales Market Share by Application (2021-2032)
- 6.3 Global Salbutamol Oral Liquid Price by Application
7 Company Profiles
- 7.1 Apotex
- 7.1.1 Apotex Company Information
- 7.1.2 Apotex Business Overview
- 7.1.3 Apotex Salbutamol Oral Liquid Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Apotex Salbutamol Oral Liquid Product Portfolio
- 7.1.5 Apotex Recent Developments
- 7.2 Aurobindo Pharma
- 7.2.1 Aurobindo Pharma Company Information
- 7.2.2 Aurobindo Pharma Business Overview
- 7.2.3 Aurobindo Pharma Salbutamol Oral Liquid Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Aurobindo Pharma Salbutamol Oral Liquid Product Portfolio
- 7.2.5 Aurobindo Pharma Recent Developments
- 7.3 Lupin Pharmaceuticals
- 7.3.1 Lupin Pharmaceuticals Company Information
- 7.3.2 Lupin Pharmaceuticals Business Overview
- 7.3.3 Lupin Pharmaceuticals Salbutamol Oral Liquid Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Lupin Pharmaceuticals Salbutamol Oral Liquid Product Portfolio
- 7.3.5 Lupin Pharmaceuticals Recent Developments
- 7.4 Perrigo Company
- 7.4.1 Perrigo Company Company Information
- 7.4.2 Perrigo Company Business Overview
- 7.4.3 Perrigo Company Salbutamol Oral Liquid Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Perrigo Company Salbutamol Oral Liquid Product Portfolio
- 7.4.5 Perrigo Company Recent Developments
- 7.5 Wockhardt
- 7.5.1 Wockhardt Company Information
- 7.5.2 Wockhardt Business Overview
- 7.5.3 Wockhardt Salbutamol Oral Liquid Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Wockhardt Salbutamol Oral Liquid Product Portfolio
- 7.5.5 Wockhardt Recent Developments
- 7.6 GlaxoSmithKline
- 7.6.1 GlaxoSmithKline Company Information
- 7.6.2 GlaxoSmithKline Business Overview
- 7.6.3 GlaxoSmithKline Salbutamol Oral Liquid Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 GlaxoSmithKline Salbutamol Oral Liquid Product Portfolio
- 7.6.5 GlaxoSmithKline Recent Developments
- 7.7 Mylan Pharmaceuticals
- 7.7.1 Mylan Pharmaceuticals Company Information
- 7.7.2 Mylan Pharmaceuticals Business Overview
- 7.7.3 Mylan Pharmaceuticals Salbutamol Oral Liquid Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Mylan Pharmaceuticals Salbutamol Oral Liquid Product Portfolio
- 7.7.5 Mylan Pharmaceuticals Recent Developments
- 7.8 Novartis Pharmaceuticals Corporation
- 7.8.1 Novartis Pharmaceuticals Corporation Company Information
- 7.8.2 Novartis Pharmaceuticals Corporation Business Overview
- 7.8.3 Novartis Pharmaceuticals Corporation Salbutamol Oral Liquid Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Novartis Pharmaceuticals Corporation Salbutamol Oral Liquid Product Portfolio
- 7.8.5 Novartis Pharmaceuticals Corporation Recent Developments
- 7.9 Sandoz
- 7.9.1 Sandoz Company Information
- 7.9.2 Sandoz Business Overview
- 7.9.3 Sandoz Salbutamol Oral Liquid Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Sandoz Salbutamol Oral Liquid Product Portfolio
- 7.9.5 Sandoz Recent Developments
- 7.10 Teva Pharmaceuticals
- 7.10.1 Teva Pharmaceuticals Company Information
- 7.10.2 Teva Pharmaceuticals Business Overview
- 7.10.3 Teva Pharmaceuticals Salbutamol Oral Liquid Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Teva Pharmaceuticals Salbutamol Oral Liquid Product Portfolio
- 7.10.5 Teva Pharmaceuticals Recent Developments
8 North America
- 8.1 North America Salbutamol Oral Liquid Market Size by Type
- 8.1.1 North America Salbutamol Oral Liquid Revenue by Type (2021-2032)
- 8.1.2 North America Salbutamol Oral Liquid Sales by Type (2021-2032)
- 8.1.3 North America Salbutamol Oral Liquid Price by Type (2021-2032)
- 8.2 North America Salbutamol Oral Liquid Market Size by Application
- 8.2.1 North America Salbutamol Oral Liquid Revenue by Application (2021-2032)
- 8.2.2 North America Salbutamol Oral Liquid Sales by Application (2021-2032)
- 8.2.3 North America Salbutamol Oral Liquid Price by Application (2021-2032)
- 8.3 North America Salbutamol Oral Liquid Market Size by Country
- 8.3.1 North America Salbutamol Oral Liquid Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Salbutamol Oral Liquid Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Salbutamol Oral Liquid Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Salbutamol Oral Liquid Market Size by Type
- 9.1.1 Europe Salbutamol Oral Liquid Revenue by Type (2021-2032)
- 9.1.2 Europe Salbutamol Oral Liquid Sales by Type (2021-2032)
- 9.1.3 Europe Salbutamol Oral Liquid Price by Type (2021-2032)
- 9.2 Europe Salbutamol Oral Liquid Market Size by Application
- 9.2.1 Europe Salbutamol Oral Liquid Revenue by Application (2021-2032)
- 9.2.2 Europe Salbutamol Oral Liquid Sales by Application (2021-2032)
- 9.2.3 Europe Salbutamol Oral Liquid Price by Application (2021-2032)
- 9.3 Europe Salbutamol Oral Liquid Market Size by Country
- 9.3.1 Europe Salbutamol Oral Liquid Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Salbutamol Oral Liquid Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Salbutamol Oral Liquid Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Salbutamol Oral Liquid Market Size by Type
- 10.1.1 China Salbutamol Oral Liquid Revenue by Type (2021-2032)
- 10.1.2 China Salbutamol Oral Liquid Sales by Type (2021-2032)
- 10.1.3 China Salbutamol Oral Liquid Price by Type (2021-2032)
- 10.2 China Salbutamol Oral Liquid Market Size by Application
- 10.2.1 China Salbutamol Oral Liquid Revenue by Application (2021-2032)
- 10.2.2 China Salbutamol Oral Liquid Sales by Application (2021-2032)
- 10.2.3 China Salbutamol Oral Liquid Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Salbutamol Oral Liquid Market Size by Type
- 11.1.1 Asia Salbutamol Oral Liquid Revenue by Type (2021-2032)
- 11.1.2 Asia Salbutamol Oral Liquid Sales by Type (2021-2032)
- 11.1.3 Asia Salbutamol Oral Liquid Price by Type (2021-2032)
- 11.2 Asia Salbutamol Oral Liquid Market Size by Application
- 11.2.1 Asia Salbutamol Oral Liquid Revenue by Application (2021-2032)
- 11.2.2 Asia Salbutamol Oral Liquid Sales by Application (2021-2032)
- 11.2.3 Asia Salbutamol Oral Liquid Price by Application (2021-2032)
- 11.3 Asia Salbutamol Oral Liquid Market Size by Country
- 11.3.1 Asia Salbutamol Oral Liquid Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Salbutamol Oral Liquid Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Salbutamol Oral Liquid Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Salbutamol Oral Liquid Market Size by Type
- 12.1.1 SAMEA Salbutamol Oral Liquid Revenue by Type (2021-2032)
- 12.1.2 SAMEA Salbutamol Oral Liquid Sales by Type (2021-2032)
- 12.1.3 SAMEA Salbutamol Oral Liquid Price by Type (2021-2032)
- 12.2 SAMEA Salbutamol Oral Liquid Market Size by Application
- 12.2.1 SAMEA Salbutamol Oral Liquid Revenue by Application (2021-2032)
- 12.2.2 SAMEA Salbutamol Oral Liquid Sales by Application (2021-2032)
- 12.2.3 SAMEA Salbutamol Oral Liquid Price by Application (2021-2032)
- 12.3 SAMEA Salbutamol Oral Liquid Market Size by Country
- 12.3.1 SAMEA Salbutamol Oral Liquid Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Salbutamol Oral Liquid Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Salbutamol Oral Liquid Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Salbutamol Oral Liquid Value Chain Analysis
- 13.1.1 Salbutamol Oral Liquid Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Salbutamol Oral Liquid Production Mode & Process
- 13.2 Salbutamol Oral Liquid Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Salbutamol Oral Liquid Distributors
- 13.2.3 Salbutamol Oral Liquid Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst